MIR3162

Across TCGA pan-cancer cohorts, MIR3162 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR3162 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR3162 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3162 expression acts as an unfavorable survival marker, although some lineages such as CHOL and LAML show a favorable association.

LUAD, UCS, and KIRP are the cancer types where MIR3162 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.201	0.785	<.001	75	view →
UCS	OS	Tertile	III,IV	0.001	0.594	<.001	66	view →
KIRP	OS	Tertile	II,III,IV	0.111	0.769	<.001	54	view →
UVM	OS	Tertile	All	0.218	0.696	.014	36	view →
CESC	DFS	Tertile	All	0.755	0.825	.032	18	view →
LIHC	DFS	Tertile	II,III,IV	0.132	0.421	.026	12	view →
CHOL	DFS	Tertile	III,IV	1.000	0.182	.034	9	view →
THCA	DFS	Tertile	IV	0.075	0.807	<.001	9	view →
LAML	DFS	Quartile	All	0.587	0.249	.017	4	view →
STAD	OS	Median	IV	0.682	0.249	.028	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR3162–LUAD (DFS)

Open the LUAD breakdown →